Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Solid Biosciences LLC (SLDB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Solid Biosciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.938 -0.062    -0.62%
12:29:04 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 34,085
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 9.750 - 10.060
Solid Biosciences 9.938 -0.062 -0.62%

Solid Biosciences LLC Company Profile

 
Get an in-depth profile of Solid Biosciences LLC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

88

Equity Type

ORD

Solid Biosciences Inc., a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. The company’s lead product candidate is SGT-003, a gene transfer candidate for the treatment of Duchenne muscular dystrophy; and SGT-501 to treat Catecholaminergic polymorphic ventricular tachycardia. It is also developing AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy; SGT-601 to treat a rare cardiac disease characterized by mutations in the gene that codes for cardiac troponin T protein, which helps coordinate contraction of the heart muscle; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, a cardiac splicing factor that regulates alternative splicing, and codes for RNA binding motif protein 20; and AVB-202-TT to treat Friedreich’s ataxia, as well as other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne; and a license agreement with the University of Washington, University of Missouri, and University of Florida. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

Contact Information

Address 500 Rutherford Avenue Third Floor
Charlestown, 02129
United States
Phone 617 337 4680
Fax -

Top Executives

Name Age Since Title
Ian F. Smith 57 2020 Executive Chair
Adam Leo Stone 43 2015 Lead Independent Director
Adam M. Koppel 53 2022 Director
Lynne Marie Sullivan 56 2015 Independent Director
Jeffrey Chamberlain - 2018 Chairman of Scientific Advisory Board
Rajeev Shah 46 2017 Independent Director
Ilan Ganot 49 2013 Co-founder, Strategic Advisor to the CEO & Director
Alexander G. Cumbo 52 2022 President, CEO & Director
Laurence A. Turka 65 - Member of Scientific Advisory Board
Michael W. Lawlor - - Member of Scientific Advisory Board
Sukumar Nagendran 56 2018 Independent Director
Geoffrey F. Slaff - - Member of Scientific Advisory Board
Carrie Miceli - - Member of Scientific Advisory Board
Jeffrey A. Bluestone 70 - Member of Scientific Advisory Board
Clare Kahn 71 2021 Independent Director
Martin I. Freed 62 2018 Independent Director
Lee Sweeney - - Member of Scientific Advisory Board
Georgia Keresty 61 2021 Independent Director
Ronald D. Cohn - - Member of Scientific Advisory Board
Dongsheng Duan - - Member of Scientific Advisory Board
Joe Kornegay - - Member of the Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SLDB Comments

Write your thoughts about Solid Biosciences LLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Raeid Alruwaili
Raeid Alruwaili Mar 19, 2021 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Run for now
Simon Hemmes
SimonGiraf Feb 23, 2021 3:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looks like a short squeeze to me.  Seeking alpha lists 109 % shorted.  Didnt know how you can be than 100 % shorted....weird.
Buy Sell
ab56 Feb 23, 2021 3:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
gamestop was 140% shorted
Darren Robertson
Darren Robertson Dec 11, 2020 1:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
big money invested this will fly
Mιχάλης Γιαννίσης
Mιχάλης Γιαννίσης Oct 05, 2020 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
goooooo
Narinder Gautam
Narinder Gautam Oct 01, 2020 8:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Solid Biosciences is a top ranked Biomedical and Genetics industry shares will and are  trading much  higher since investors are expecting a big move regarding its high level  Options .Remember that on Thursday FDA  has approved the continuation of its clinicsl trial of  IGNITE DMD Phase 1/2 clinical trial.
Nicolas Daoud
Nicolas Daoud Oct 01, 2020 1:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In at 4.77 any help?
Stephen Appiah
Stephen Appiah Oct 01, 2020 1:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Got in at same rate. Sold at loss @4.31
john bull
Bullybearz Oct 01, 2020 1:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do a research before you take risks
Farry Hardianto
Farry Hardianto Oct 01, 2020 1:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why not SHORTing the stock instead? 4.77 good for bounce short.
Fred Seow
Fred Seow Oct 01, 2020 11:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will test 7
Mick West
googleMickWest Oct 01, 2020 11:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you put your money on that?
Fred Seow
Fred Seow Oct 01, 2020 11:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Am long this stock since a month ago!
Mιχάλης Γιαννίσης
Mιχάλης Γιαννίσης Oct 01, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
rally will start soon 🏎️🏎️🏎️🏎️
Jean Sc
Jean Sc Oct 01, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why?
Mιχάλης Γιαννίσης
Mιχάλης Γιαννίσης Oct 01, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good new coming up !
Jean Sc
Jean Sc Oct 01, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ok thank you
Jean Sc
Jean Sc Oct 01, 2020 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Farry Hardianto
Farry Hardianto Oct 01, 2020 10:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think SLDB will close below 4.
Kofi Kofi
Kofi Oct 01, 2020 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I use ThinkorSwim, Anytime I try to buy durring premarket it doesn't get filled. What's the brokerage account to use to day trade fellas? Any help?
Muhammad Naveed
Muhammad Naveed Oct 01, 2020 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lightspeed, etrade both really good but i would prefer Lightspeed
Kofi Kofi
Kofi Oct 01, 2020 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Muhammad Naveed  Thanks. I need to start getting things right.
classical classics Kowach
classical classics Kowach Oct 01, 2020 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fidelity and there trader pro is free and works great
classical classics Kowach
classical classics Kowach Oct 01, 2020 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thinkswimsucks
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email